BackgroundRelapsed and refractory multiple myeloma (RRMM) is a bone marrow cancer that requires systemic treatment. which often results in severe symptom burden. Recent studies have found that electronic patient-reported outcome (ePRO) interventions implemented in the clinic setting have had positive outcomes for other oncology populations. Evidence of the efficacy of a similar approa... https://cosmeticssquadets.shop/product-category/protectors/